User profiles for R von Kummer
von Kummer RProfessor of Neuroradiology, TU Dresden, Germany Verified email at uniklinikum-dresden.de Cited by 89191 |
[HTML][HTML] Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of …
Background Alteplase is effective for treatment of acute ischaemic stroke but debate continues
about its use after longer times since stroke onset, in older patients, and among patients …
about its use after longer times since stroke onset, in older patients, and among patients …
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement
…, AJ Yoo, P Khatri, TA Tomsick, R Von Kummer… - Stroke, 2013 - Am Heart Assoc
Methods A hybrid approach based on established processes described by Glaser15 and by
the National Institutes of Health (http://prevention. nih. gov/cdp/about. aspx) 16 was used to …
the National Institutes of Health (http://prevention. nih. gov/cdp/about. aspx) 16 was used to …
Imaging of acute stroke
KW Muir, A Buchan, R von Kummer, J Rother… - The Lancet …, 2006 - thelancet.com
Thrombolytic therapy has led to a higher proportion of patients presenting to hospital early,
and this, with parallel developments in imaging technology, has greatly improved the …
and this, with parallel developments in imaging technology, has greatly improved the …
[HTML][HTML] Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
…, T Machnig, D Schneider, R Von Kummer… - New England journal …, 2008 - Mass Medical Soc
Background Intravenous thrombolysis with alteplase is the only approved treatment for acute
ischemic stroke, but its efficacy and safety when administered more than 3 hours after the …
ischemic stroke, but its efficacy and safety when administered more than 3 hours after the …
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
KR Lees, E Bluhmki, R Von Kummer, TG Brott, D Toni… - The Lancet, 2010 - thelancet.com
Background Early administration of intravenous recombinant tissue plasminogen activator (rt-PA)
after ischaemic stroke improves outcome. Previous analysis of combined data from …
after ischaemic stroke improves outcome. Previous analysis of combined data from …
[HTML][HTML] Endovascular therapy after intravenous t-PA versus t-PA alone for stroke
…, B Yan, FL Silver, R Von Kummer… - … England Journal of …, 2013 - Mass Medical Soc
Background Endovascular therapy is increasingly used after the administration of intravenous
tissue plasminogen activator (t-PA) for patients with moderate-to-severe acute ischemic …
tissue plasminogen activator (t-PA) for patients with moderate-to-severe acute ischemic …
[HTML][HTML] Thrombectomy within 8 hours after symptom onset in ischemic stroke
Background We aimed to assess the safety and efficacy of thrombectomy for the treatment
of stroke in a trial embedded within a population-based stroke reperfusion registry. Methods …
of stroke in a trial embedded within a population-based stroke reperfusion registry. Methods …
Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
W Hacke, M Kaste, C Fieschi, R Von Kummer… - The Lancet, 1998 - thelancet.com
Background Thrombolysis for acute ischaemic stroke has been investigated in several
clinical trials, with variable results. We have assessed the safety and efficacy of intravenous …
clinical trials, with variable results. We have assessed the safety and efficacy of intravenous …
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS)
…, M Kaste, C Fieschi, D Toni, E Lesaffre, R Von Kummer… - Jama, 1995 - jamanetwork.com
… From the Departments of Neurology (Dr Hacke) and Neuroradiology (Dr von Kummer), …
von Kummer R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator …
von Kummer R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator …
'Malignant'middle cerebral artery territory infarction: clinical course and prognostic signs
…, M Spranger, M De Georgia, R von Kummer - Archives of …, 1996 - jamanetwork.com
Background: Although the clinical features of space-occupying ischemic stroke are well
known, there are limited prospective data on the clinical course of complete middle cerebral …
known, there are limited prospective data on the clinical course of complete middle cerebral …